Formation of thiazolidine-2,4-dicarboxylic acid, the L-cysteineglyoxylate adduct, is the putative mechanism by which L-cysteine reduces hepatic oxalate production from glycollate [Bais, Rofe and Conyers (1991) J. Urol. 145, 1302-1305. This was investigated in isolated rat hepatocytes by the simultaneous measurement of both adduct and oxalate formation. Different diastereoisomeric ratios of cis-and trans-adduct were prepared and characterized to provide both standard material for the enzymic analysis of adduct in hepatocyte supernatants and to investigate the stability and configuration of the adduct under physiological conditions. In the absence of L-cysteine, hepatocytes produced oxalate from 2 mM glycollate at a rate of 822 + 42 nmol/30 min INTRODUCTION
INTRODUCTION
Urinary oxalate is the most significant risk factor in the formation of calcium oxalate stones, with reductions in urinary oxalate excretion decreasing the risk of stone formation in an exponential manner (Robertson, 1984) ; thus any reduction in oxalate production produced by treatment with L-cysteine would be of clinical significance. Previous studies from this laboratory indicate that the control of oxalate production is in the final pathway in which the immediate precursors of oxalate, namely glycollate and glyoxylate, are metabolized (Rofe et al., 1976; Bais et al., 1989 Bais et al., , 1991a . L-Cysteine, a ,-aminothiol, is known to react rapidly with glyoxylate under physiological conditions to yield thiazolidine-2,4-dicarboxylic acid, the L-cysteineglyoxylate adduct. Considerable evidence exists to suggest that adduct formation occurs physiologically (Burns et al., 1984; Hamilton, 1985; Venkatesan and Hamilton, 1986) . In addition, orally administered adduct is excreted rapidly and exhibits very low toxicity (LD50 for rats and mice = 2 g/kg) (Alary et al., 1989) . We have previously investigated the effects of ,-aminothiols on oxalate production from glyoxylate in vitro (Bais et al., 1991b) and the effect of L-cysteine and L-2-oxothiazolidine-4-carboxylate on urinary oxalate excretion (Baker et al., 1994; Bais et al., 1991b) . The present study investigates whether formation of the L-cysteine-glyoxylate adduct is the mechanism by which Lcysteine decreases oxalate production from glycollate in hepatocytes. Glycollate is preferentially used as the oxalate precursor in investigations of the effects of L-cysteine on oxalate production, as it requires transport into the cells before it is metabolized in the peroxisomes by glycollate oxidase to glyoxylate. When glyoxylate is used as the oxalate precursor, adduct formation can occur either inside or outside the cell, whereas any reduction in oxalate production from glycollate caused by L-cysteine can essentially be attributed to the intracellular formation of the adduct.
per 107 cells. The addition of L-cysteine to the incubation medium at 1.0, 2.5 and 5.0 mM lowered oxalate production by 14 + 2, 25 + 3 (P < 0.05) and 38 + 3 % (P < 0.01) respectively. These reductions were accompanied by almost stoichiometric increases in the levels of the adduct: 162 + 6, 264 + 27 and 363 + 30 nmol/30 min per 107 cells. Adduct formation is therefore confirmed as the primary mechanism by which L-cysteine decreases oxalate production from glycollate. As urinary oxalate excretion is a prime risk factor in the formation of calcium oxalate stones, any reduction in endogenous oxalate production is of clinical significance in the prevention of this formation. Preparation and characterization of thlazolidine-2,4-dicarboxylic acid, the L-cysteine-glyoxylate adduct Thiazolidine-2,4-dicarboxylic acid (100% cis-adduct) was prepared by mixing equal amounts of aq. 1.6 M (L-cysteine and glyoxylate in a glass scintillation vial (pH not adjusted before addition, final pH 1.4), and the 51 % cis-adduct was prepared by mixing equal amounts of aq. 1.6 M L-cysteine and glyoxylate in a glass scintillation vial (pH adjusted to 7.4 before addition). After mixing, the vials were evacuated with nitrogen and sealed. The reaction was allowed to proceed for 3 h at 80 0C in a shaking water bath at 80 oscillations/min. At the completion of the reaction the precipitate was collected and washed three times with ethanol before freeze-drying. The precipitate was found to be pure 100 % cis-adduct or 51 % cis-adduct respectively. The purity of the preparation and the structure of the adduct were confirmed by capillary tube melting-point determinations, proton n.m.r., KBr disc i.r. spectroscopy and gas chromatography/ electron-impact m.s. Proton n.m.r. spectra of the adduct were obtained on a Bruker ACP 300 MHz spectrometer using [2H] dimethyl sulphoxide as the solvent and 1 % tetramethylsilane as the reference. Adduct stereochemistry was confirmed by proton n.m.r. (McMillan and Stoodley, 1968 Enzymic assay of thiazolidine-2,4-dicarboxylic acid
MATERIALS AND METHODS
The L-cysteine-glyoxylate adduct was determined spectrophotometrically on a Cobas Bio Analyser using bovine kidney Daspartate oxidase (Dixon and Kenworthy, 1967) . Physiological concentrations of cis-adduct are an excellent substrate for Daspartate oxidase; trans-adduct is not a substrate for this enzyme (Hamilton, 1985) . (Dixon and Kenworthy, 1967 Figure 2 Electron-impact mass spectrum of the trimethylsilyl derivative of 100% cis-thlazolidine-2,4-dicarboxylic acid
The inserts show (a) the structure of the trimethylsilyl derivative of 100% cis-thiazolidine-2,4-dicarboxylic acid and the molecular fragment which gives rise to the peak at mass/charge 204 and (b) the molecular ion at mass/charge 321.
Investigations Into the effect of L-cysteine on production of Immediately after the addition of 1.5 ml of cold 1 M citric acid to the cell suspension in the incubation vial, a small inner vial (1.0 x 4.5 cm) containing 0.2 ml of 1 M hyamine hydroxide in methanol was inserted and the incubation vial capped. After 2 h at room temperature, the inner vial was removed, the exterior washed with distilled water, and the radioactivity, representing metabolic production of 14CO2, measured after the addition of 3.5 ml of scintillant (0.4 % 2,5-diphenyloxazole in toluene). (Figure ic) . Slow thermodynamic epimerization has also been observed with 5,5-dimethylthiazolidine-2,4-dicarboxylic acid, the D-penicillamineglyoxylate adduct (Bringmann et al., 1992) . The splitting patterns and chemical shifts observed in the proton-n.m.r. spectra of the adduct agree with predictions based on first principles for the suggested structure (Kemp, 1987) . The ratio of calculated mass to observed mass of the molecular ion of the trimethylsilyl derivative of the 100 % cis-adduct (Figure 2) , assuming silylation at both carboxylic acid functional groups, was 1.00, confirming the overall elemental composition of the adduct. In addition, the fragmentation patterns and major ion fragments confirm the overall molecular structure. The i.r. spectra (Figure 3) confirmed the presence of the secondary amine functional group (broad peak at 3600-3200 cm-') and the carbonyl moieties on the carboxylic acid functional groups (sharp peak at 1680 cm-1) Figure 3 KBr disc i.r. spectra of 100% (-) and 51% (--cisthlazolldine-2,4-dicarboxylic acid
The sharp peak at 1680 cm-is indicative of the carbonyl moiety on the carboxylic acid functional groups whereas the broad peak at 3600-3200 cm-is indicative of the secondary amine functional group. (Kemp, 1987) . Sharp melting points corresponding to those observed by Forneau et al. (1971) confirmed the purity of both diastereoisomeric preparations: 186°C for 100 % cis-adduct and 188°C for 51 % cis-adduct. On reaching the melting point, the samples bubbled vigorously indicating release of CO2 from the carboxylic acid functional groups. Two PKa values for 100 % cisadduct were found to be 3.90 and 9.25 corresponding to one of the carboxylic acid functional groups and the secondary amine functional group respectively. It is reasonable to assume that the PKa for the other carboxylic acid functional group is below 2 as the adduct is a strongly acidic dicarboxylic acid (Aylward and Findlay, 1987) . Thus at pH 7.4, the adduct exists with both dicarboxylic acid functional groups deprotonated and the secondary amine functional group protonated.
Investigations into the effect of 8-aminothiols on production of
[14C]oxalate and 14CO2 from [1-14C] 
glycollate by hepatocytes
Glycollate is metabolized to oxalate in the peroxisomes either directly by glycollate dehydrogenase or indirectly by glycollate oxidase with glyoxylate as an intermediate (Figure 4) (Fry and Richardson, 1979; Yanagawa et al., 1990) . Glyoxylate can react readily with L-cysteine to form the L-cysteine-glyoxylate adduct. Adduct formation has previously been postulated as the mechanism by which (a) L-cysteine decreases oxalate production from glyoxylate in vitro (Bais et al., 199 lb) and (b) L-cysteine and L-2-oxothiazolidine-4-carboxylate lower urinary oxalate excretion (Baker et al., 1994) . In the present study hepatocytes incubated in the absence of L-cysteine produced oxalate from 2 mM glycollate at a rate Results are expressed as means+S.E.M. for three independent hepatocyte preparations. *P < 0.05, **P < 0.01 and ***P < 0.001, compared with controls. 264+27 (P<0.01) and 363+30 (P<0.01)nmol/30min per l07 cells respectively. A significant correlation between the decrease in oxalate production and the formation of the L-cysteine-glyoxylate adduct was shown to exist: adduct formation (nmol/30 min per 107 cells) = (0.84 + 0.17) + (1.09 + 0.03) (decrease in oxalate) (r = 0.94; P < 0.001). This observation supports the view that formation of L-cysteine-glyoxylate adduct is the mechanism by which L-cysteine decreases oxalate production from glycollate.
In addition to oxalate production, glyoxylate can be converted into glycine by alanine-glyoxylate aminotransferase. Rat liver cytosol, microsomes, lysosomes and peroxisomes contain 25 % of the total cellular activity of this enzyme (Rowsell et al., 1972) , and thus the observation that adduct formation accounted for 9+3 % more glyxoylate than the decrease in oxalate can be explained by the fact that the additional adduct comes from glyoxylate that under normal conditions would undergo transamination (Figure 4) (Figure 4 ) before reaching the mitochondria for decarboxylation. Thus the majority of CO2 produced from glycollate is probably from the H202-dependent non-enzymic decarboxylation of glyoxylate in the peroxisomes. The observation that L-cysteine had no effect on CO2 production while significant diminishing oxalate production through formation of the L-cysteineglyoxylate adduct suggests that the majority of CO2 production in the peroxisome occurs before L-cysteine-glyoxylate adduct formation. H202 and glyoxylate are formed as a result of the oxidation of glycollate by glycollate oxidase (Schuman and Massey, 1971) . Thus, with respect to the rest ofthe cell, glyoxylate and H202 are present in relatively high concentrations near the active site of this enzyme. It can be postulated that, as glyoxylate and H202 diffuse from the enzyme surface, the glyoxylate is rapidly decarboxylated by the high local concentration of H202, resulting in CO2 production. This process will slow as diffusion from the enzyme surface proceeds and the relative concentrations of glyoxylate and H202 are diminished. In addition, the high activity of catalase in peroxisomes will deactivate the H202 as it diffuses from the enzyme surface. The remaining glyoxylate diffusing out can then undergo L-cysteine-glyoxylate adduct formation (Figure 4) .
The results of this study indicate that other f,-aminothiols, particularly D-cysteine and D-penicillamine, may be able to decrease oxalate production from glycollate through formation of the respective ,J-aminothiol-glyoxylate adduct. In addition, it now seems probable that the reduction in urinary oxalate excretion previously observed on feeding L-cysteine (Bais et al., 1991b) and L-2-oxothiazolidine-4-carboxylate (Baker et al., 1994) is due to the formation of the L-cysteine-glyoxylate adduct. 
